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ABSTRACT
Background: Concerns related to adverse 
health effects experienced by aircrew exposed 
to aircraft contaminated air have been ongoing 
for over 6 decades. Unfiltered breathing 
air is supplied to the cabin via the engine 
compressor. The likelihood that oil leaking 
over the engine oil seals may enter the cabin 
air supply has prompted continuing debate 
about the hazards associated with exposure 
to neurotoxic substances and to the thermally 
degraded or pyrolysed mixture. In this study, 
we undertook an in-depth investigation 
of aircrew involved in suspected aircraft 
contaminated air events.
Methods: Two studies were conducted to 
review the circumstances and symptoms of 
a cohort of aircrew working in the pressurized 
air environment of aircraft. A table of effects 
was then used for categorizing symptoms and 
reviewing other sources of data related to 
aircraft fluids and selected other conditions.
Results: Both acute and chronic exposures 
to neurotoxic and a wide range of thermally 
degraded substances were confirmed, along 
with a clear pattern of acute and chronic 
adverse effects. The latter were supported 
by medical findings and diagnoses, notably 
involving the neurological, neurobehavioural 
and respiratory systems.
Conclusion: A clear cause and effect 
relationship has been identified linking the 
symptoms, diagnoses and findings to the 
occupational environment. Recognition of this 
new occupational disorder and a clear medical 
investigation protocol are urgently needed.
Keywords: AEROTOXIC SYNDROME, AEROTOXICITY, CABIN AIR CONTAMINATION, CABIN AIR QUALITY, JET ENGINE OILS, OIL 
FUMES, TCP
INTRODUCTION
In 1955, the first civilian aircraft adopted the military 
practice of bleeding unfiltered air (so-called bleed 
air) from engine compressors to supply the cabin 
ventilation system. Adverse effects on crew exposed 
to low levels of synthetic jet engine oil leaking over 
the oil seals were soon observed (1). It was promptly 
recognized that air bled from the engine compressors 
was contaminated via internal engine oil leakage 
into the compressor air (2). Hydraulic and de-icing 
fluids may also contaminate incoming engine air. 
Military studies found that the base stock of engine 
oils produce a wide variety of toxic substances as 
temperatures increase (i.e. when pyrolysed) (3).
Turbine engines utilize synthetic lubricants that 
generally include an ester base stock (95%), a wide 
variety of triaryl phosphates (TAPs), organophosphate 
(OP) anti-wear additives (around 3%), amine 
antioxidants and proprietary ingredients (1–2%). The 
commercial formulation of the OP additive is generally 
cited as tricresyl phosphate (TCP). Exposure of such 
substances to extreme temperatures generates a large 
number of pyrolysed compounds and hydrocarbons. 
Hydraulic fluids are made up primarily of tributyl 
phosphates (TBPs) and triphenyl phosphates, while de-
icing fluids consist of ethylene and propyl glycols.
Over the last 2 decades, many ad hoc air-monitoring 
studies have been performed during normal engine 
operations. These have focused on TCP, which is 
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routinely found in 25–100% of air samples taken during 
flights (4). TBP was identified in 73% of flights, while 
low levels of TBP and triphenyl phosphate metabolites 
have been found in 100% of urine samples.
While increasing numbers of reports and case studies 
have been published over the years, there has been 
much debate about the contamination sources 
and components, toxicity, consistency of signs and 
symptoms, and lack of causal mechanism (5–7). The 
lack of an accepted international protocol for the 
medical investigation of crew and passengers after an 
air quality incident means that consistent data has 
been difficult to obtain. This is further complicated by 
the fact that, at the levels encountered, the toxicants 
tend to cause a diffuse set of neurological and other 
symptoms currently classified as nonspecific.
The aim of this study was to undertake an in-depth 
investigation of aircrew involved in suspected aircraft 
contaminated air events to determine whether the 
reported symptoms and diagnoses are consistent 
with exposure to pyrolysed jet engine oil and engine/
aircraft fluids or to other factors.
METHODS
Two independent studies were conducted to review the 
circumstances and symptoms of a cohort of aircrew 
working in the pressurized air environment of aircraft 
in which bleed air contamination was recognized to 
occur. A table of effects was then used to categorize 
symptoms and review other sources of data related to 
aircraft fluids and selected other conditions.
First, in a BAe 146 aircraft pilot health survey PhD 
research project (study A) (8), United Kingdom 
pilot unions were requested to supply a list of all 
known United Kingdom certified BAe 146/146 Avro 
RJ aircraft (BAe 146) pilots. In all, 274 BAe 146 pilots 
(14% of the known total; 7% women) responded 
to a telephone interview or written questionnaire 
regarding their contaminated air exposure history, 
health effects and medical diagnoses. Data were 
collected (by SM) from 2005 to 2009 on demographics, 
flying history, flight deck air quality history, health 
effects and other comments. Of these, 142 of the 
pilots reported specific symptoms and diagnoses, 
30 reported adverse health effects, but provided no 
detail, while 77 reported no health effects and 25 
failed to advise either way.
The second study was a case study analysis of 15 
potential cabin air quality incidents (study B). The 
incidents were selected because they were reported 
to be consistent with acute hyperventilation and 
hypoxia (9) and extensive data was available. Data 
sources included: airline, crew and maintenance 
reports; incident investigation and regulator 
reports; health effects and medical records; and 
media, union and legal reports. The incidents took 
place in Australia, Germany, the United Kingdom 
and the United States of America. Extensive data 
on the aircraft flight history, acute and long-term 
effects on crew, medical diagnoses and findings, and 
maintenance findings were collated.
A table was then developed to categorize acute 
and chronic symptoms. Study A included 142 pilots 
reporting specific symptoms, while study B included 
specific symptoms reported per incident, rather 
than per person. Substances utilized in the oils and 
hydraulic and de-icing fluids were then assessed 
against the European Regulation EC No. 1272/2008 on 
classification, labelling and packaging of substances 
(CLP), hazard classifications (10) and hazard databases. 
Symptoms were compared with published literature 
on cabin air, hyperventilation and hypoxia. Study 
A reviewed the workplace environment and general 
health of the group of pilots, whereas study B reviewed 
the various associated health and operational factors 
of the 15 suspected contaminated air events.
Authors of this paper include a qualified respiratory 
physician (JB) and medical pathologist (CVH), who 
are competent to analyse and interpret the health 
effects outlined in the studies. The first author 
(SM) is a commercial pilot with a PhD and MSc in 
this research area, and is thus uniquely qualified to 
perform the data assessment.
RESULTS
STUDY A
Study A included the 219 pilots who reported either 
specific (n = 142) or no (n = 77) health effects (8). Adverse 
effects (ranging from acute to long-term symptoms) 
included cardiovascular, gastrointestinal, general (fatigue, 
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performance decrement) irritant, neurobehavioural, 
neurological and respiratory effects (Fig. 1).
Fig. 2 shows that of the 274 pilots surveyed, 88% were 
aware of exposure to aircraft contaminated air. In 
all, 34% reported frequent exposures, 18% reported 
one to two big events and 7% reported visible smoke 
or mist events, with most reporting fumes only. In 
all, 63% reported immediate (i.e. acute, occurring 
during the flight) to long-term (i.e. chronic, lasting 
for >6 months) adverse health effects; 44% reported 
acute or short-term effects (lasting for days to weeks); 
and 32% reported medium-term (lasting for weeks to 
months) chronic effects consistent with suspected 
contaminated air exposures.
Of the 274 pilots, 36 (13%) had died or had experienced 
chronic ill health leading to a permanent loss of fitness 
to fly. The types of adverse effects and diagnoses 
described were: neurobehavioural, 64%; neurological 
and general factors (e.g. chemical sensitivity, chronic 
fatigue, gastrointestinal (GI) symptoms), 53%; 
respiratory, 39%; and cardiovascular, 25%. The chronic 
cohort (13%) reported ill health at 37–433% above the 
controls. In all, 10% of the pilots had flown the BAe 146 
for under 2 years, 54% for 3–10 years and 19% for over 11 
years.
STUDY B
A range of findings for study B were identified based 
on 15 selected incidents (shown in Table 1). In all, 80% 
of events involved fumes only, 53% took place on 
the flight deck and 27% took place in both the flight 
deck and cabin. All events involved non-steady state 
(i.e. transient) engine operation, with 80% occurring 
during a climb and or descent. The incidents occurred 
in seven different aircraft types and 87% were linked 
to positive maintenance findings of oil leakage. In all, 
66% of events involved further reports of fumes both 
before and after the incident.
Symptoms ranging from in-flight incapacitation to 
impairment were reported in 93% of events, with the 
majority (73%) involving pilots and 33% including full 
or partial incapacitation of two pilots. In all, 53% of 
events included long-term adverse effects for one or 
more crew members. Almost 75% of events included 
adverse effects in more than one crew member and 
47% of events reported 10–23 different symptoms. 
In total, 73% of events were associated with some 
form of medical investigation soon after the incident, 
with less than 50% providing a variety of medical 
findings (shown in Table 2). Chronic medical findings/
diagnoses were found for two thirds of events (shown 
in Table 2), including cardiovascular, neurobehavioural, 
neurological and respiratory symptoms, chronic 
fatigue, multiple chemical sensitivity, aerotoxic 
syndrome, cancer, soft tissue damage, and chemical 
exposure. Nine pilots either became unfit to fly or died. 
Passengers reported adverse effects in 27% of events.
This study highlights links to a variety of operational 
factors: most events involved non-visible fumes only, 
low use of emergency oxygen and checklists by pilots, 
failure to report events as required, inadequate fault 
identification, with residual events occurring, with 
most events caused by oil leakage.
FIG 1. STUDY A: BAe 146 AIRCRAFT PILOT HEALTH SURVEY - 
HEALTH EFFECTS (N = 219)
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FIG. 2. STUDY A: BAe 146 PILOT  ADVERSE HEALTH EFFECTS 
(N = 274)
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TABLE 1. STUDY B: KEY FINDINGS
CATEGORY Column A
TYPE OF EVENT Fumes x 12;    Fumes & haze or smoke x 3
LOCATION Flight deck x 8;   Cabin x 3;   Flight deck & cabin x 4
PHASE OF FLIGHT Climb & or descent x 12;   After start x 1;   Various phases x 2
ENGINE OPERATION Non steady state engine operation x 15
AIRCRAFT TYPES BAe 146 x 5;  A 330 x 2;  A 319 x 2;  B757 x 3 
B737 x 1;   B767 x1;   B747 x 1
PREVIOUS REPORTS OF FUMES ON AIRCRAFT 10
FOLLOWING REPORTS OF FUMES ON AIRCRAFT 10
MAINTENANCE FINDINGS Oil x11;    Oil & hydraulic x 2;   Unknown x 2 (1 possible oil overfill)
LEVEL OF EFFECT (AT TIME OF EVENT)- Pilots & cabin 
crew
Incapacitation & or partial incapacitation x 7; 
Incapacitation & impairment x 2; 
Impairment x 5
LEVEL OF EFFECT (AT TIME OF EVENT) -Pilot(s) Incapacitation - Full & or partial x 7; 
Incapacitation & impairment x 1; 
Impairment- all x 4
2 Pilot incapacitation- Full or partial 5
TIME OF EFFECT Immediate (in-flight) x 14; 
Short to medium-term x 12; 
Long-term x 8
NUMBER OF ACUTE SYMPTOMS REPORTED /INCIDENT 1 - 9 x 8;    10 - 23 x 7
>1 CREW MEMBER AFFECTED 11
PASSENGERS EFFECTED 4
MEDICAL TESTS UNDERTAKEN AT TIME OF EVENT 11
MEDICAL FINDINGS AT TIME OF EVENT 7
MEDICAL FINDINGS/DIAGNOSIS LATER ON 10
LOSS OF PILOT MEDICAL CERTIFICATE/ ABILITY TO 
FLY
9
LOSS OF CABIN CREW LONG-TERM FITNESS TO FLY 5
USE OF OXYGEN Both pilots x 6;  1 pilot x 3;  All crew x 0
DELAYED USE OF OXYGEN BY PILOTS 5
OXYGEN HELPED 8
EMERGENCY CHECKLIST USED BY PILOTS 2
REPORTING AS REQUIRED 9
AIR ACCIDENT INVESTIGATION BUREAU REPORT 10
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OVERVIEW SURVEY
Table 3 lists a range of acute and chronic 
symptom clusters with low to high prevalence 
in the selected studies. Study A found moderate 
acute central nervous systems (CNS), general, GI, 
neurobehavioural and irritant effects. Moderate 
levels of chronic cardiovascular, general (fatigue, 
performance decrement, rheumatological), irritant, 
neurobehavioural, neurological and respiratory 
effects were reported. Study B found high rates of 
acute GI, neurobehavioural, neurological, respiratory, 
performance decrement and irritant effects, and 
moderate levels of chronic, GI, neurobehavioural, 
neurological, respiratory effects and general effects 
such as chemical sensitivity, fatigue and performance 
decrement skin and irritant effects.
TABLE 2. STUDY B: INDEPENDENT MEDICAL FINDINGS/DIAGNOSES BY MEDICAL STAFF
SHORT-TERM MEDICAL FINDINGS & DIAGNOSES No. LONG-TERM MEDICAL FINDINGS & DIAGNOSES No.
Hydrocarbon fume inhalation/chemical injury on 
aircraft 
1 RADS (Reactive Airways Dysfunction Syndrome) /
occupational asthma 
6
Adverse effect on the vocal chords and bronchial 
tubes
1 PTSD (Post Traumatic Stress Disorder) 3
Tricresyl phosphate (TCP) in blood 1 Neurotoxic injury 1
Raised levels of VOCs, nickel, cell degradation 1 Toxic encephalopathy 1
Double hernia due vomiting 1 Neuropathy on vocal chords/limbs 3
Poisoning by non-medical agent 5 MCS (Multiple Chemical Sensitivity) 1
SPO2 70% / 80% (peripheral capillary oxygen 
saturation)
2 CFS (Chronic Fatigue Syndrome) 1
Abnormal blood results: CK; CK-MB; LDH; GOT 
(AST); GPT (ALT) 
2 Anxiety/depression 1
Traumatic muscle damage and ischemia due 
excessive athletic sports or contamination
2 Cognitive dysfunction 4
Toxic effect of gas, fumes or smoke 2 Dementia 1
Possible inhibition of the enzyme AChe or other 
neurospecific esterase caused by organophosphates 
2 ADHD (Attention Deficit Hyperactivity Disorder ) 1
Toxicopy 2 Seizure disorder 1
carboxyhemoglobin at or above the high normal 
range - exposure to burned organic chemicals
4 Depression 1
TOCP (Triortho cresyl phosphate) adduct on Bche 1 Aerotoxic syndrome 1
Inhalation injury 1 Chemical injury at work 1
Organophosphate (OP) type poisoning/internal 
bleeding
1 Neurological chemical injury 1
CNS injury 1
G4 GBM (deceased) - (Glioblastoma brain tumour) 1
Wallerian degeneration 1
Vocal polyps 1
Heart attack + phosphate exposure (deceased) 1
Frontal lobe damage 1
Optic nerve damage 1
Migraines 1
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TABLE 3. OVERVIEW SURVEY
SYMPTOM Study A Study B CLP- Haz-
ard clasifi-
cation
Litera-
ture
Hazard Data-
basesf
HYPOXIA HYPERVEN-
TILATION
n=142 15 incidents (harmo-
nized/noti-
fied)
No of pilots report-
ing Symptoms
No of incidents/
symptom
- oil, hy-
draulic, 
deicing fluid 
- oil, hydraulic, 
deicing fluid 
Acute Chronic Acute Chronic Acute Chronic
NEUROLOGICAL X X X
    CENTRAL (CNS) X X X
Incapacity/paralysis; Im-
paired/loss of consciousness
9 (6%) 1 (1%) 15 (100%) X X X loss con-
sciousness
semi con-
sciousness
Headache /Pressure in head/
trouble speaking
47 (33%) 21  (15%) 11  (73%) 5  (33%) X X X headache headache
Balance problems/erratic 
movement/ataxia
11  (8%) 7   (5%) 2  (13%) 1  (7%) X X X
Vision problems/tunnel or 
double vision/dilated pupils/
nystagmus
11 (8%) 10  (7%) 8  (53%) 1  (7%) X X unrespon-
sive pupils
visual dis-
turbances
PERIPHERAL (PNS)  
Motor;Sensory;Autonomic
X X X
Shaking/tremors; Inco-ordi-
nation/motor response
12  (9%) 17   
(12%)
11  (77%) 6  (40%) X X X shakes/
twitches
Paraesthesiae/numbness in 
limbs/other; Peripheral neu-
ropathy
12  (9%) 25  (18%) 5  (33%) 7  (46%) Neurotoxic-
ity, Single 
& repeat 
exposure
X X X tingling/
numbness
Sweaty/temperature control/
pallor/flushing/taste
7  (5%) 6   (4%) 3  (21%) 6  (60%) X X X sweating sweats/hot/
cold
NEUROBEHAVIOURAL X X X
   NEUROLOGICAL X X
Discomfort/intoxication/diso-
rientation/ 
confusion
16  (11%) 3   (2%) 10  (66%) 1  (7%) X X confusion/ 
disorienta-
tion
confusion/ 
disorienta-
tion
Behavioural/personaility 
Changes;unreality/anxiety/
depression
1   (1%) 20  (14%) 7  (46%) X X X unreality unreality/
anxiety
Dizziness/light-headedness/
lethargy/drowsiness 
21  (15%) 9   (6%) 11  (73%) 3  (20%) Drowsi-
ness/ 
dizzi-
ness:CNS
X X X light head-
edness
light head-
edness
   COGNITIVE X X dizziness
Cognitive problems: problem 
solving/concentration/memo-
ry/writing
46  (32%) 58  (41%) 14 (93%) 9  (60%) X X X cognitive 
problems
cognitive 
impairment
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TABLE 3. OVERVIEW SURVEY
SYMPTOM Study A Study B CLP- Haz-
ard clasifi-
cation
Litera-
ture
Hazard Data-
basesf
HYPOXIA HYPERVEN-
TILATION
n=142 15 incidents (harmo-
nized/noti-
fied)
No of pilots report-
ing Symptoms
No of incidents/
symptom
- oil, hy-
draulic, 
deicing fluid 
- oil, hydraulic, 
deicing fluid 
Acute Chronic Acute Chronic Acute Chronic
Giggling/euphoric 2  (13%) X X euphoria
GASTROINTESTINAL X X
Nausea/vomiting/ Diarrhoea 25  (18%) 14  (10%) 14 (93%) 5  (33%) Harmful if 
swallowed
X X X nausea/
vomiting
Cramps/bloating/pain/diges-
tive problems
2   (1%) 4  (27%) 2  (13%) Harmful/
fatal if in-
haled
X X X bloating/
belching
RESPIRATORY Respiratory 
tract irri-
tant
Breathing problems/cough/
chest discomfort/wheezing/
lung irritation
15   (11%) 34  (23%) 11  (73%) 4  (27%) Respiratory 
sensitiza-
tion Allergy/ 
asthma / 
difficulty 
breathing
X X X breathing 
problems
breathing 
problems
CARDIOVASCULAR chest pain
Chest pain/ tightness/variable 
heart rate/palpitations/BP
6   (4%) 21 (14%) 5   (33%) X X variable 
heart rate/
palpitations
irregular 
heart rate/
palpitations
 GENERAL: rheumatological; 
miscellaneous; soft tissue 
Target 
organ tox-
icity-single/
repeat
Joint/muscle pain/aches/
twitches/weakness
8   (6%) 23 (16%) 4  (27%) 2  (13%) Liver; uri-
nary tract; 
heart;
X X X weakness
Feeling unwell/performance 
decrement
33 (23%) 54 (38%) 15  (100%) 3  (20%) Respira-
tory; sys-
temic; CNS
X
Fatigue/chronic fatigue/ex-
haustion
27 (19%) 65  (46%) 3  (20%) 6  (40%)  blood; 
kidneys
X X X fatigue exhaustion
Chemical sensitivity 3  (2%) 13 (9%) 5  (33%) X
Vocal/nasal/ throat polyps/
swelling
1  (7%) 1  (7%) X
IRRITATION
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TABLE 3. OVERVIEW SURVEY
SYMPTOM Study A Study B CLP- Haz-
ard clasifi-
cation
Litera-
ture
Hazard Data-
basesf
HYPOXIA HYPERVEN-
TILATION
n=142 15 incidents (harmo-
nized/noti-
fied)
No of pilots report-
ing Symptoms
No of incidents/
symptom
- oil, hy-
draulic, 
deicing fluid 
- oil, hydraulic, 
deicing fluid 
Acute Chronic Acute Chronic Acute Chronic
Eye, nose, throat & voice ir-
ritation/burning/redness/
hoarseness
41 (29%) 14 (11%) 15  (100%) 3  (21%) Eye irrita-
tion
X X X dry mouth
SKIN Skin irri-
tant/
skin sensi-
tization
Skin reaction/blisters/rash 
(uncovered areas); Burning 
scalp/alopecia
7   (5%) 11 (8%) 4  (27%) 5  (34%) Harmful-
skin expo-
sure
X X X bluish/red 
skin
IMMUNE SYSTEM Genetic 
defects
other other other
Recurrent respiratory tract 
infections/altered immune 
system
11  (8%) 12 (8%) 1  (7%) Damage: 
fertility/ 
unborn
X
CANCERS 9 (6%) 1  (7%) Carc 1B/2 
- bladder; 
liver
X X
e X indicates symptom present.
f Hazardous Substances Data Bank, International Chemical Safety Card, US National Institute for Occupational Safety and Health.
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The globally harmonized hazard classification system 
(i.e. CLP) for levels of substances present in oil and 
hydraulic and de-icing fluids lists a wide range of 
mandatory (harmonized) and non-mandatory (notified) 
hazard warnings. These include CNS, inhalation, 
neurotoxic and skin warnings; single and repeat 
exposure organ toxicity (systemic, CNS, respiratory 
and other); eye, skin and respiratory irritation; 
respiratory and skin sensitization; and genetic, 
reproductive and carcinogenic hazards. Key hazard 
databases (e.g. Hazardous Substances Data Bank, 
International Chemical Safety Card, US National 
Institute for Occupational Safety and Health) include 
a range of acute and chronic hazards associated 
with substances present in aircraft fluids, including 
cardiovascular, carcinogenic, GI, general, irritant, 
neurobehavioural, neurological, respiratory and skin 
effects. The available literature on exposure to aircraft 
fluids covers all categories identified. The adverse 
effects of hyperventilation and hypoxia cover some of 
the same categories.
DISCUSSION
Bleed air contamination has been recognized since 
the introduction of the bleed air system in the 1950s 
and remains a problem through to the present day (2, 
7, 11–14). All current transport aircraft, except for the 
Boeing 787, use the bleed air system to provide cabin 
ventilation. Transient, low-level oil leakage over the 
engine oil seals into the aircraft air supply occurs 
during normal flight operations, with less frequent, 
higher level leakage under certain operational 
conditions (e.g. seal wear or seal failure) (4). The use of 
pressurized air from the engine compressor to both 
seal the oil-bearing chamber and supply cabin bleed 
air provides a mechanism for low-level oil leakage in 
routine engine operations (4, 15). While many experts 
have suggested that oil leakage is associated only with 
rare failure events, others now recognize that chronic 
exposure is caused by the so-called tiny amounts 
of oil vapours released by oil leaking continuously 
over the seals during engine power changes (4, 16). 
The manufacturer of aircraft described in study 
A acknowledged that all engines leak oil, that the 
amount of oil leaked by their engines was previously 
greater than the industry average, and that there was 
a general health and safety problem, but no in-flight 
safety issues (17).
Although there have been many attempts to determine 
the frequency of oil fume events from available 
reports, underreporting is widely recognized (8, 
12). Thus, the population exposed to low-level oil 
fumes in flight is considered to comprise all crew 
and passengers. In 2015, this represented 3.5 billion 
passengers and around 0.5 million crew members.
The debate on cabin air contamination commonly 
focuses on ad hoc air-monitoring findings undertaken 
during normal flight operations. However, a number 
of smaller case studies have been undertaken over 
the last 6 decades. An early case study reported eye, 
nose and throat irritation, nausea, chest tightness, 
breathing difficulties, fatigue, light-headedness, 
dizziness, faintness, headache, vision problems and 
a metallic taste (1). A number of case studies describing 
cardiovascular, general, GI, irritant, neurobehavioural, 
neurological and respiratory effects of cabin air have 
also been reported (see Table 4.11 in (8)). Further case 
studies have focused on exposure to a mixture of 
volatile organic compounds and OPs (18, 19). The results 
presented here are consistent with the findings of 
these studies.
A syndrome consists of a group of signs and 
symptoms, some or all of which consistently occur 
together (although not all need be present), and can be 
recognized as a distinct entity. It has been suggested 
that aerotoxic syndrome, first described in 2000 (20), 
is not a medical entity. Additionally, the reported 
symptoms are suggested to be “so broad and non-
specific and can have many causes that it is difficult 
to define or discern a precise illness or syndrome” 
(14). Physicians make a diagnosis on the merits of 
the case at hand and will then prescribe appropriate 
treatment. However, the information required for 
identifying a syndrome is not available at the level of 
the individual patient, but rather at the population 
level – it is epidemiological in nature. The symptoms 
associated with chronic low-dose exposure to OPs 
are acknowledged to be nonspecific and diffuse. For 
these reasons, clinicians who only treat one exposure 
case at a time may feel able to dismiss the concept of 
aerotoxic syndrome.
This overview study is the first to report extensive 
findings from two different cohorts. There were clear, 
consistent acute and chronic patterns of adverse 
effects, including CNS and peripheral nervous system 
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(PNS; motor, sensory and autonomic nervous systems); 
neurobehavioural (neurological and cognitive systems); 
gastrointestinal; respiratory; cardiovascular; general 
(rheumatological, performance decrement, fatigue, soft 
tissue damage); irritant, skin and sensitizing effects.
Study A found that aircrew had a high level of 
awareness of working in a contaminated air 
environment, along with a higher rate of repeated, low-
level background fume events, while study B identified 
acute exposures occurring in addition to general 
chronic exposures. Therefore, the so-called acute-
on-chronic effects of exposure to OPs and pyrolysed 
mixtures must be considered. As shown in Fig. 3, 
studies A and B identified different rates of symptoms; 
however, there is a clear pattern of primarily 
neurological and respiratory symptoms.
The medical findings and diagnoses, while significant 
and consistent with exposure to substances in aircraft 
fluids and to complex, thermally degraded mixtures, 
have not been well recognized within the aviation 
industry. Primary data has been lost for a number 
of reasons, including lack of a recognized medical 
protocol, lack of an aircraft air-monitoring system, 
a general reluctance to volunteer information on 
an issue that is not accepted by the airline industry, 
lack of education about aircraft contaminated air, 
difficulties associated with maintenance investigations 
for bleed air contamination, and reluctance by airlines 
to investigate such events. There is a clear disincentive 
to report health effects when a commercial pilot’s 
licence and career depend on good health (8, 21).
The lack of an internationally accepted protocol 
for investigating aircraft fume events hampers our 
understanding of the consequences of such exposure. 
A useful protocol should include: checklists for 
sampling aircraft air and surfaces, along with adequate 
numbers of appropriate collection and storage 
containers; and specimen collection (blood, urine) 
using standard methods from crew and passengers 
within maximum time limits or at stated collection 
times. Adopting such protocols would enable the 
collection of standardized, consistent data which 
would, in turn, facilitate a better understanding of 
the medical consequences of fume exposure. Progress 
in this field is hampered by a general lack of medical 
training in toxicology.
TCP has neurotoxic properties (22), but the widespread 
belief that only ortho isomers of TCP are dangerous 
is invalid. The 99.7% of non-ortho isomers of TCP 
and TAP can cause nerve demyelination and inhibit 
various enzymes, including those linked to cognition 
(23–25).
It is widely accepted that high concentrations of OP 
compounds poison enzyme systems and have direct 
toxicological influences on living cells. These properties 
were first exploited for the development of nerve gases 
and later for insecticides. Although OPs can bind to 
FIG. 3. STUDIES A AND B: PREVALENCE OF CHRONIC AND 
ACUTE (A) NEUROLOGICAL, (B) NEUROBEHAVIOURAL AND 
(C) NON-NEUROLOGICAL SYMPTOMS
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many different enzymes, their best-known actions 
are on cholinesterases and neuropathy target esterase 
(NTE). The principal mode of action is to disturb 
the process of acetylcholine metabolism, a natural 
neurotransmitter substance found in the CNS and 
PNS. Neurotransmitters normally have a short half-
life because they are rapidly destroyed by specific 
enzymes. This prevents their build-up; if further signal 
is required, then more neurotransmitter is secreted 
from neurons. When OPs poison acetylcholinesterase, 
the resulting increase in acetylcholine concentration 
overstimulates acetylcholine receptors, causing CNS 
and PNS symptoms. People exposed to a fume event 
have reductions in acetylcholinesterase and NTE 
activity (18). CNS symptoms include ataxia, drowsiness, 
headache, poor concentration and visual disturbances, 
with higher doses leading to coma. PNS symptoms 
include altered muscle tone, tremor and paraesthesae 
(pins and needles).
However, OPs can have more subtle effects at lower 
doses, particularly with repeated exposures. Terry 
reviewed non-cholinergic mechanisms of OP toxicity, 
including covalent binding of OPs to tyrosine and 
lysine residues, which suggests that numerous 
proteins can be modified by OPs (26). In addition, OP 
concentrations of up to three orders of magnitude 
below those required for cholinesterase inhibition can 
(i) cause oxidative stress and neuroinflammation and 
(ii) affect known OP targets such as motor proteins, 
neuronal cytoskeleton proteins, axonal transport, 
neurotrophins and mitochondria.
Tri-o-cresyl phosphate has been shown to cause 
primary axonal degeneration and subsequent 
secondary demyelination (27). Thus, the 
symptomatology of OP exposure tends to be rather 
nonspecific. Indeed, it is relevant that multiple 
sclerosis, a demyelinating disease, can present as 
almost any combination of neurological symptoms – it 
can thus be described as protean. In a similar way, OP 
exposure damage tends not to cause a clear-cut set 
of localizing signs and symptoms that are instantly 
recognizable as a syndrome, but rather to a pattern of 
diffuse neurological symptoms. This is consistent with 
their mode of action and the resulting diagnosis of 
diffuse toxic encephalopathy.
The very-low-dose effects described by Terry (26) 
support the exposure pattern among aircrew described 
in the present studies – chronic, continual, low-dose 
exposure with occasional acute-on-chronic, higher-
dose episodes. This scenario could explain the apparent 
differential vulnerability between aircrew and 
passengers. Supporting evidence for this hypothesis 
was provided by an in vitro study in which pre-
exposure of neuroblast cells to very-low-dose OPs made 
them much more susceptible to neurotoxic damage 
compared with non-pre-exposed cells upon further 
challenge by a higher dose of a variety of OPs (28).
Individual susceptibility to damage by OP exposure 
appears to be highly variable. Some people have 
constitutionally low levels of liver enzymes, such as 
paraoxonases, that detoxify OPs in the liver. It was 
demonstrated that farmers with lower paraoxonase 
levels are more likely to suffer from dippers flu as 
a result of exposure to OP sheep dips (29). This finding 
may help explain why not all aircrew appear to be 
equally affected by fume events. It also goes some 
way toward explaining the apparent differential 
susceptibility between aircrew and passengers.
Respiratory symptoms are likely to be secondary to 
direct irritation or damage to lung tissue. Substances 
that are not toxic individually may become highly 
toxic within a pyrolysed mixture (13). There is growing 
evidence that the response to low-level exposure 
to mixtures of toxic substances can differ from the 
response to acute, high-dose exposure to single toxins 
(30, 31). The predominance of respiratory symptoms 
(second only to neurological symptoms) in these 
studies should be considered direct evidence of the 
presence of appreciable levels of irritants in cabin air 
during fume events.
Some researchers suggest there is no causative agent 
or that there is a temporal association only between 
exposures and adverse effects (7, 9). However, the 
findings from the present study are consistent with 
previous reports which accept that the Bradford 
Hill causation criteria are met in eight out of nine 
categories (the exception was a dose–response 
relationship) (8). This study identified a cause–
effect relationship for exposure and symptoms 
and diagnosis; thus, disease findings are linked to 
occupational and environmental exposure. Causation 
is also accepted elsewhere (32).
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Numerous arguments have been used to deny 
the recognition of aerotoxic syndrome as a new 
occupational disease. Levels of contaminants are often 
reported to be below exposure standards. However, 
the use of such standards does not apply to the 
public, at altitude or to a complex pyrolysed mixture 
(33). Furthermore, industry accepted standards are 
designed to protect most (but not all) of exposed 
individuals. It is well recognized that some individuals 
will develop disease at environmental concentrations 
well below these standards. Furthermore, the effects 
are said to be inconsistent with tri-o-cresyl phosphate-
associated, OP-induced delayed neuropathy, while 
ignoring all other indicators of toxicity; thus, nocebo 
is the suggested mechanism (7). The studies reported 
herein identify PNS neuropathy along with one case 
of OP-induced delayed neuropathy (characterized by 
Wallerian degeneration) associated with confirmed oil 
findings, among a range of other effects and diagnoses.
Hyperventilation and hypoxia were also suggested 
to be responsible for the observed symptoms (9), but 
this was based upon reports of selected symptoms 
only. Although hyperventilation may occur in 
stressful situations, to argue that fume-affected 
aircrew suffer from a hyperventilation syndrome 
simply because their symptoms resemble those 
seen in a hyperventilating person is to ignore the 
fact that overbreathing also occurs in individuals 
with cardiac, lung and neuromuscular disorders. 
Furthermore, if symptoms are, in fact, due to stress-
related hyperventilation, this would call into question 
the industry’s selection process for aircrew. Hypoxia 
will prompt hyperventilation, but if this is accepted 
as the cause of the symptoms, then it follows that 
the fume inhalation must have caused organic 
injury. Additionally, this rationale ignores the strong 
correlation between observed symptoms and the 
hazard classification process and databases.
CONCLUSIONS
Aircraft air supplies contaminated by pyrolysed engine 
oil and other aircraft fluids can reasonably be linked to 
acute and chronic symptoms, findings and diagnoses, 
thus establishing causation. Other potential causes of 
symptoms have been suggested. However, these fail to 
recognize that:
• the design mechanism allows chronic low-level 
exposure to a complex mixture during both normal 
flight and specific incident events with confirmed 
leakage;
• observed effects are consistent with those of 
recognized hazards;
• acute effects and operational limitations reduce 
flight safety;
• chronic effects are common; and
• passengers occupy the same environment as crew.
Over 3.5 billion passengers and 0.5 million aircrew 
were exposed to low levels of engine oils in 2015 
(34–36). There is an obvious need for a clearly 
defined internationally recognized medical protocol, 
occupational syndrome and disease recognition, and 
health and environmental data collection.
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